학술논문
35 - MGTA-145, in Combination with Plerixafor in a Phase 1 Clinical Study, Mobilizes Large Numbers of Hematopoietic Stem Cells and a Graft with Potent Immunosuppressive Properties for Autologous and Allogeneic Transplant
Document Type
Abstract
Author
Source
In Transplantation and Cellular Therapy March 2021 27(3) Supplement:S34-S34
Subject
Language
ISSN
2666-6367